CompletedNot Applicable

A Case Report of NMDAR Encephalopathy

United States1 participantsStarted 2024-06-20

Plain-language summary

This case illustrates the clinical, radiologic, and histopathologic features of Anti-NMDAR encephalitis and underscores the importance of MRI in detecting ovarian teratomas when pelvic ultrasound is inconclusive.

Who can participate

Age range34 Years – 34 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Suspected Anti-NMDA Encephalitis Exclusion Criteria: * Inability to consent

What they're measuring

Anti-NMDA Encephalitis

Timeframe: 1 week

Trial details

NCT IDNCT06915103

SponsorMayo Clinic

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2024-07-08

View on ClinicalTrials.gov More Anti-NMDA Receptor Encephalitis trials